Global Comprehensive Synthetic Biology Markets Report 2017:

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Mar 9, 2017 at 7:00 AM 539

Global Comprehensive Synthetic Biology Markets Report 2017: Market Reached Nearly $3.9 Billion in 2016 and Should Reach $11.4 Billion by 2021

Dublin, March 09, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Synthetic Biology: Global Markets" report to their offering. Report Includes: - An overview of the global markets for synthetic biology. - Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021. - Coverage of core synthetic biology products: synthetic genes, other DNA parts, chassis organisms, synthetic cells - Coverage of enabling technologies: DNA sequencing, oligonucleotides, specialty media, bioinformatics - Coverage of enabled technologies: biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture - Analysis of the synthetic biology industry structure, competitors and intellectual property landscape - An assessment of the products and technologies most commercially viable in the immediate and near-future time frame. - Profiles of major players in the industry The study scope includes core synthetic-biology products (synthetic genes, biobrick parts, delivery plasmids, chassis organisms, synthetic cells, production systems), enabling technologies (DNA sequencing, DNA synthesis and assembly, genome editing, bioinformatics and specialty media) and enabled technologies (biofuels, chemicals, pharmaceuticals, agriculture) that are already commercialized or are forecast to be commercialized within the next five years. We analyze key synthetic-biology technologies and products to determine present and future market status, and forecasted growth from 2016 through 2021. We also discuss strategic alliances, industry structures, competitive dynamics, patents and market driving forces. The synthetic-biology industry is examined by market segment, including the following segments: DNA sequencing; DNA synthesis; genome editing; synthetic-biology foundries; industrial biotechnology; pharmaceuticals; and agriculture. The role of key strategic alliances and acquisitions from 2014 through 2016 is discussed.

Emerging markets including synthetic genes, synthetic-biology-enabled drugs and vaccines, genome-edited crops, chassis organisms, as well as metabolically engineered factories for producing synthetic fuels and specialty chemicals are analyzed, and more than 135 companies in these fields are highlighted. Key Topics Covered: 1: Introduction - Study Goals And Objectives - Reasons For Doing The Study - Contribution Of The Study And For Whom - Scope And Format - Methodology - Information Sources 2: Summary 3: Overview - Synthetic-Biology Technologies Covered In This Report - What Is Synthetic Biology? - Development Stage Of Synthetic Biology - Forces Driving Synthetic-Biology Market Growth - Global Markets For Synthetic-Biology Products - Life-Cycle Status Of Products And Technologies - Synthetic-Biology Industry 4: Synthetic-Biology Technologies - Introduction - Synthetic-Biology Technology Overview - Enabling Technologies - Biologic Components And Integrated Systems Technologies - Enabled Technologies - Pathway Engineering - Research And Development Applications - Biofuels Technologies 5: Synthetic-Biology Applications - Enabling Technologies Applications - Biologic Components And Integrated Systems Applications - Enabled Products Applications 6: Synthetic-Biology Industry - Industrial Biotechnology Value Chain - Industry Structural Forces - Products And Technology Life Cycle - Dna-Sequencing Instrument Industry - Third-Generation Sequencing Industry - Oligonucleotide Synthesis Industry - Gene-Synthesis Industry - Genome-Editing Tools Industry - Synthetic-Biology Foundries Industry - Pharmaceuticals Industry - Agriculture Industry - Acquisitions And Strategic Alliances 7: Synthetic-Biology Markets - Industry Growth-Driving Forces - Synthetic-Biology Markets By End-User Industry - Synthetic-Biology Market By Product Type - Enabled Products Market - Regional Markets 8: Patents - Introduction - Foundational Patents - Synthetic-Biology Industry Patent Analysis - Genome Editing - Crispr/Cas9 Patent Landscape 9: Company Profiles - 20N Labs Inc. - Abeona Therapeutics Inc. - Active Motif - Agilis Biotherapeutics Llc - Agrivida - Algenuity - Ambrx Inc. - Amyris Inc. - Araknitek - Arzeda Corp. - Astrazeneca Plc - ATG Biosynthetics GMBH - Atum - Avidbiotics Corp. - BASF AG - Bayer AG - Beta Renewables - Bioamber Inc. - Bio Basic Canada Inc. - Biomax Informatics AG - Bioneer Corp. - Bio S&T Inc. - Bluebird Bio - Blue Marble Biomaterials - Bolt Threads - British Petroleum - Bristol-Myers Squibb - Calysta Inc. - Cargill Inc. - Caribou Biosciences Inc. - Cell Design Labs - Cellectis SA - Chain Biotechnology Ltd - Cibus Inc. - Codexis Inc. - Demuris Limited - Desktop Genetics Ltd. - DOW Chemical Company - E.I. Du Pont De Nemours And Company - Dyadic International Inc. - Editas Medicine Inc. - Enbiotix Inc. - Enevolv Inc. - Epoch Life Science Inc. - Eurofins Mwg Operon - Evolva SA - Evonetix - Exxonmobil Corp. - Gen9 Inc. - Genemed Synthesis Inc. - Gene Oracle Inc. - Geneworks Pty. Ltd. - Genomatica - Genscript - Gevo Inc. - Ginkgo Bioworks - Glaxosmithkline Plc - Global Bioenergies - Glycos Biotechnologies Inc. - Goodyear Tire & Rubber Co. - Green Biologics Ltd. - Helix Nanotechnologies Inc. - Illumina Inc. - Industrial Microbes Inc. - Ingenza Ltd. - Inovio Pharmaceuticals Inc. - Integrated Dna Technologies Inc. - Intellia Therapeutics - International Business Machines - Intrexon Corp. - Joule Unlimited - Juno Therapeutics Inc. - Labgenius Ltd. - Lanzatech - Lattice Automation Inc. - Lc Sciences - Lygos Inc. - Merck & Co. - Metabolix Inc. - Michelin Sa - Microsoft Corp. - Modular Genetics Inc. - Morphosys AG - Myriant Technologies Llc - New England Biolabs - Novartis Pharma AG - Novozymes A/S - Omega Bio-Tek Inc. - Oragenics Inc. - Origene Technologies Inc. - Pacific Biosciences Of California Inc. - Pfizer Inc. - Phylogica Limited - Phytowelt Green Technologies GMBH - Precision Biosciences - Prokarium Holdings Ltd. - Qteros Inc. - Radiant Genomics Inc. - Rennovia Inc. - Roosterbio Inc. - Royal DSM NV - Sample6 Technologies - Sangamo Therapeutics Inc. - Sanofi-Aventis - Scarab Genomics Llc - Sea6 Energy Pvt Ltd. - Sgi-Dna Inc. - Shanghai Generay Biotech Co. Ltd. - Shanghai Shinegene Molecular Bio-Technologies Inc. - Sigma Aldrich Corp. - Silicolife Lda. - Soligenix Inc. - Spiber Inc. - Synlogic - Synpromics Ltd. - Synthace Ltd. - Synthetic Biologics Inc. - Synthetic Genomics Inc. - Synthorx Inc. - Synvitrobio Inc. - Taxa Bio-Engineering - Teewinot Life Sciences Corp. - Terravia Holdings Inc. - Teselagen Biotechnology Inc. - Thermo Fisher Scientific Inc. - Touchlight Genetics Ltd - Transcriptic Inc. - Triton Algae Innovations Ltd. - Twist Bioscience - Verdezyne Inc. - Ziopharm Oncology Inc. - Zymergen For more information about this report visit http://www.researchandmarkets.com/research/g2pbqf/synthetic

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Biotechnology

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celebree Gains Franchise Momentum: A New Frontier

The Climb: Celebree Schools on the Rise Here's a nugget in the franchise world that's causing a stir: Celebree School is making moves up the Franchise Times Top 400. When we're talking about a hop, skip, and jump through 84 spots since 2023, you can't help but notice. It's the third year in a row they're climbing this ladder, and it's making ripples. Franchise Expansion...

Veterans Transitioning to Real Estate with Scholarships

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Home Buying: Unmasking All the Real Budget Costs

Home Buying: More Costs Than Meets the Eye Let's face it, buying a home is no stroll in the park. It's a tangled web of numbers and surprises that can leave even the savviest buyer in a daze. Thank goodness for articles like the one from HelloNation featuring Serena LoPiccolo-Smith, which make the invisible visible when it comes to the financial intricacies of home...

Omneky Outshines Competitors in AI Ad Scoring

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Skiptown Expands in Georgia Amid Growing Demand

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Montessori and Tech: A New Era of Integration

Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...

New American Funding Expands in Carolinas with Mullinix Move

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Coventry's Jacobs Joins European Life Settlement Execs

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

VetsinTech's AI Training Boosts Military Careers

A New Spin on Engineering Careers Sometimes it feels like every corner I turn in this market maze, there’s something about AI. It’s not just chirping in the tech world anymore; it’s banging on the doors of sectors like engineering, aerospace, and manufacturing. And now, VetsinTech is tossing its hat into the AI ring with a fresh program aimed at blending military...

Partner Valuation Advisors Bolsters Team with Eichman

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...